RMD
Resmed
$203.08
+$7.81 (+4%)Jul 27, 2026
Key metrics
The numbers that frame RMD today
- Market cap
- $29.46B
- P/E (TTM)
- 19.4
- EV / FCF
- 16.3
- Gross margin
- 61.6%
- EV / Sales
- 5.2
- ROIC
- 59.1%
- Div yield
- 1.15%
- Debt / equity
- 0.1
- 52wk Low
- $180.27
- 52wk High
- $291.53
Growth
Revenue and earnings trend for RMD
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about RMD
Is Resmed a good buy?
Yes. Resmed has excellent quality, and it outweighs the poor momentum here. Growth looks strong, which supports the long-term business case. We think Resmed is selling at a low price.
What is the market capitalization of RMD?
Resmed's market capitalization is $29.46B.
What is the P/E ratio for RMD stock?
Resmed's current P/E ratio is 19.4.
What is the 52-week high for RMD stock?
The 52-week high for Resmed is $291.53. The current close of $203.08 is 30.3% below that high.
What is the 52-week low for RMD stock?
The 52-week low for Resmed is $180.27. The current close of $203.08 is 12.7% above that low.
Does RMD stock pay dividends?
Resmed pays a dividend. The latest dividend per share in the company data is $2.33, which implies a yield of 1.15% based on the current close.
What is the Debt / Equity ratio for RMD?
Resmed's Debt / Equity ratio is 0.13.